See other companies on Welcome to the Jungle

CardioLogs

Leveraging AI to detect heart conditions

CardioLogs logo
21-100 employees
  • Healthcare
  • B2B
  • Artificial Intelligence
  • SaaS
  • MedTech
Bonne-Nouvelle, Paris, France

Company mission

To democratize expert cardiac care through medical-grade artificial intelligence.

10% employee growth in 12 months

Our take

In the world of cardiology, the growth of AI is set to be a real game changer. Medical centres have been quick to realise the challenges they face in managing care for patients with cardiac conditions, in particular the time it takes to read and assess the growing number of ECGs being processed.

Cardiologs is a clinical decision support system (CDSS) designed to help physicians detect anomalies in a patient’s heart activity. Though it primarily focuses on detecting atrial fibrillation - a condition which affects around 33 million people globally - Cardiologs is highly scalable, and capable of spotting more than 100 different kinds of cardiac abnormalities.

With clinical studies proving that Cardiolog's deep learning AI greatly outperforms its counterparts, the company is a stand-out in the market. In 2021 it was acquired by Philips, a global leader in health technology, which will enable the larger company to expand its value while affording Cardiologs the resources to continue innovation and development.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Benefits

  • Annual offsite
  • Mobility package
  • Flexible WFO/ WFH policy
  • Breakfast & Co
  • Weekly Yoga class
  • Referral program
  • F&B Vouchers
  • Monthly drinks

Funding (last 2 of 7 rounds)

Jan 2020

$15m

SERIES A

Oct 2017

$6.4m

SERIES A

Total funding: $23m

Leadership

Roy Jakobs

(CEO (Philips))

Joined Philips in 2010 as CMO/CSO/EVP. They then held several other leadership roles at the company, ultimately becoming CEO in 2022.

Jobs (3)

All locations

Software Engineering

Sales & Account Management